^
Association details:
| Biomarker: | No biomarker |
|---|---|
| Cancer: | Marginal Zone Lymphoma |
| Drug: | Leukeran (chlorambucil) (Alkylating agent) |
| Direction: | Sensitive |
Evidence:
Source:
Excerpt:
Marginal Zone Lymphoma: First-line therapy for elderly or infirm…Other recommended regimens…Chlorambucil ± rituximab
